透过GLASS看胶质瘤:弥漫性胶质瘤的分子演化与胶质瘤纵向分析联盟
成人弥漫性胶质瘤在诊断时分子特征已有全面认识,但疾病进展过程中发生显著的细胞与分子演化。本文综述原发肿瘤及复发后的基因组与表观遗传异常,指出文献空白,并介绍胶质瘤纵向分析联盟(GLASS)如何通过多机构系统性编目纵向变化,以揭示可靶向的脆弱点并改善患者结局。
要点
- 成人弥漫性胶质瘤在进展过程中发生显著的细胞与分子演化。
- 原发肿瘤诊断时分子特征已较清楚,但复发后的基因组与表观遗传异常存在文献空白。
- GLASS联盟旨在系统性编目胶质瘤纵向变化,以揭示可靶向脆弱点并改善结局。
核心结论
- GLASS计划将提供胶质瘤向致死表型演化的关键见解,有望揭示可靶向的脆弱点并最终改善有需求患者群体的结局。
研究设计与样本
- 综述:总结原发肿瘤及复发后基因组与表观遗传异常,指出文献空白,并阐述GLASS多机构纵向分析的必要性与目标。
主要发现
- 癌症基因组图谱(TCGA)及类似项目已提供胶质瘤诊断时体细胞改变和分子亚型的全面认识。
- 胶质瘤在疾病进展期间经历显著的细胞和分子演化。
- 原发肿瘤与复发后的基因组和表观遗传异常存在文献空白。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult diffuse gliomas are a diverse group of brain neoplasms that inflict a high emotional toll on patients and their families. The Cancer Genome Atlas and similar projects have provided a comprehensive understanding of the somatic alterations and molecular subtypes of glioma at diagnosis. However, gliomas undergo significant cellular and molecular evolution during disease progression. We review the current knowledge on the genomic and epigenetic abnormalities in primary tumors and after disease recurrence, highlight the gaps in the literature, and elaborate on the need for a new multi-institutional effort to bridge these knowledge gaps and how the Glioma Longitudinal Analysis Consortium (GLASS) aims to systemically catalog the longitudinal changes in gliomas. The GLASS initiative will provide essential insights into the evolution of glioma toward a lethal phenotype, with the potential to reveal targetable vulnerabilities and, ultimately, improved outcomes for a patient population in need.
引用
- Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium. Neuro Oncol. 2018. PMID: 29432615. doi:10.1093/neuonc/noy020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。